SOHO 2022 Tenth Annual Meeting
Playback speed
10 seconds
SOHO 2022: Pivotal Results From a Phase I/II Study of Mosunetuzumab Monotherapy for Patients With R/R FL Who Have Received ≥2 Prior Lines of Therapy
By
SOHO 2022 Tenth Annual Meeting
FEATURING
Loretta Nastoupil
By
SOHO 2022 Tenth Annual Meeting
FEATURING
Loretta Nastoupil
40 views
October 14, 2022
Comments 0
Login to view comments.
Click here to Login
Lymphoma